Acknowledgement
This study was supported by the National Research Foundation of Korea (NRF) and funded by the Ministry of Science and ICT, Republic of Korea (no. NRF-2017R1A2B2004398, NRF-2021R1A2C209370611), and the Korea Institute of Science and Technology (KIST) Institutional Program (2E31623).
References
- Thrift AG, Thayabaranathan T, Howard G et al (2017) Global stroke statistics. Int J Stroke 12, 13-32 https://doi.org/10.1177/1747493016676285
- Maron BJ (2018) Clinical course and management of hypertrophic cardiomyopathy. NJEM 379, 655-668 https://doi.org/10.1056/NEJMra1710575
- Rowin EJ, Maron BJ and Maron MS (2020) The hypertrophic cardiomyopathy phenotype viewed through the prism of multimodality imaging: clinical and etiologic implications. Cardiovasc Imag 13, 2002-2016 https://doi.org/10.1016/j.jcmg.2019.09.020
- Laflamme MA and Murry CE (2011) Heart regeneration. Nature 473, 326-335 https://doi.org/10.1038/nature10147
- Garg P, Morris P, Fazlanie AL et al (2017) Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med 12, 147-155 https://doi.org/10.1007/s11739-017-1612-1
- Babuin L and Jaffe AS (2005) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173, 1191-1202 https://doi.org/10.1503/cmaj/051291
- Mueller T, Gegenhuber A, Poelz W and Haltmayer M (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91, 606-612 https://doi.org/10.1136/hrt.2004.037762
- Toldo S and Abbate A (2018) The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol 15, 203-214 https://doi.org/10.1038/nrcardio.2017.161
- Kang MJ, Seong Y, Mahmud J and Nguyen BT (2020) Obscurin and clusterin elevation in serum of acute myocardial infarction patients. Bull Korean Chem Soc 41, 266-273 https://doi.org/10.1002/bkcs.11955
- Chan D and Ng LL (2010) Biomarkers in acute myocardial infarction. BMC Med 8, 1-11 https://doi.org/10.1186/1741-7015-8-1
- Watkins SJ, Borthwick GM and Arthur HM (2011) The H9C2 cell line and primary neonatal cardio myocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47, 125-131 https://doi.org/10.1007/s11626-010-9368-1
- Manso AM, Li R, Monkley SJ et al (2013) Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload. J Biol Chem 288, 4252-4264 https://doi.org/10.1074/jbc.M112.427484
- Bandaru S, Ala C, Zhou AX and Akyurek LM (2021) Filamin A regulates cardiovascular remodeling. Int J Mol Sci 22, 6555
- Lee SY, Kim DY, Kwak MK et al (2019) High circulating follistatin-like protein 1 as a biomarker of a metabolically unhealthy state. Endocr J 66, 241-251 https://doi.org/10.1507/endocrj.EJ18-0352
- Paszek E, Zmudka K, Plens K, Legutko J, Rajs T and Zajdel W (2020) Evaluation of profilin 1 as a biomarker in myocardial infarction. Eur Rev Med Pharmacol Sci 24, 8112-8116
- Yang D, Wang Y, Jiang M et al (2017) Downregulation of profilin-1 expression attenuates cardiomyocytes hypertrophy and apoptosis induced by advanced glycation end products in H9c2 cells. Biomed Res Int 2017, 9716087
- Klopsch C, Gaebel R, Lemcke H et al (2018) Vimentin-induced cardiac mesenchymal stem cells proliferate in the acute ischemic myocardium. Cells Tissues Organs 206, 35-45 https://doi.org/10.1159/000495527
- Gong DH, Dai Y, Chen S et al (2019) Secretory vimentin is associated with coronary artery disease in patients and induces atherogenesis in ApoE(-/-) mice. Int J Cardiol 283, 9-16 https://doi.org/10.1016/j.ijcard.2019.02.032
- Zhou X, Tian F, Sandzen J et al (2007) Filamin B deficiency in mice results in skeletal malformations and impaired microvascular development. Proc Natl Acad Sci USA 104, 3919-3924 https://doi.org/10.1073/pnas.0608360104
- Carrascosa JL, Llorca O and Valpuesta JM (2001) Structural comparison of prokaryotic and eukaryotic chaperonins. Micron 32, 43-50 https://doi.org/10.1016/S0968-4328(00)00027-5
- Li JY, Patterson M, Mikkola HK, Lowry WE and Kurdistani SK (2012) Dynamic distribution of linker histone H1.5 in cellular differentiation. PLoS Genet 8, e1002879
- Bauden M, Kristl T, Sasor A et al (2017) Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma. BMC Cancer 17, 810
- Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL and Hayoz D (2004) Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61, 2614-2623 https://doi.org/10.1007/s00018-004-4225-6
- Severino V, Farina A and Chambery A (2013) Analysis of secreted proteins. Methods Mol Biol 1002, 37-60 https://doi.org/10.1007/978-1-62703-360-2_4
- Hernandez-Ruiz L, Valverde F, Jimenez-Nunez MD et al (2007) Organellar proteomics of human platelet dense granules reveals that 14-3-3ζ is a granule protein related to atherosclerosis. J Proteome Res 6, 4449-4457 https://doi.org/10.1021/pr070380o
- Thompson WC and Goldspink PH (2022) 14-3-3 protein regulation of excitation-contraction coupling. Pflug Arch Eur J Phy 474, 267-279 https://doi.org/10.1007/s00424-021-02635-x
- Mugabo Y, Zhao C, Tan JJ et al (2022) 14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells. JCI insight 7, e156378
- Zhou Q, Li L, Zhao B and Guan K (2015) The hippo pathway in heart development, regeneration, and diseases. Circ Res 116, 1431-1447 https://doi.org/10.1161/CIRCRESAHA.116.303311
- Zhou W and Zhao M (2018) How hippo signaling pathway modulates cardiovascular development and diseases. J Immuno Res 2018, 3696914
- Seo J and Kim J (2018) Regulation of hippo signaling by actin remodeling. BMB Rep 51, 151-156 https://doi.org/10.5483/BMBRep.2018.51.3.012